Review: taking Claritin and Remicade together


Summary

Drug interactions are reported among people who take Claritin and Remicade together. This review analyzes the effectiveness and drug interactions between Claritin and Remicade. It is created by eHealthMe based on reports of 683 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Claritin

Claritin has active ingredients of loratadine. It is often used in hypersensitivity. (latest outcomes from Claritin 38,014 users)

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 117,365 users)

On Sep, 17, 2016

683 people who take Claritin, Remicade are studied.


Number of reports submitted per year:

Claritin and Remicade drug interactions.

Drug effectiveness over time:

Claritin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Remicade:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Claritin:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)
Remicade:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Claritin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Remicade:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • infusion related reaction
  • dyspnoea
  • chest pain
  • back pain
  • arthralgia
  • hyperhidrosis
  • rash
  • arthritis
  • fall
  • pain
1 - 6 months:
  • infusion related reaction
  • arthralgia
  • dyspnoea
  • dizziness
  • hyperhidrosis
  • pain
  • acute respiratory distress syndrome
  • atrial flutter
  • drug effect decreased
  • drug ineffective
6 - 12 months:
  • dehydration
  • infusion related reaction
  • syncope
  • diarrhoea
  • drug ineffective
  • back pain
  • chills
  • crohn's disease
  • dizziness
  • dyspnoea
1 - 2 years:
  • drug ineffective
  • infusion related reaction
  • nephrolithiasis
  • arthralgia
  • bronchitis
  • diarrhoea
  • drug effect decreased
  • eating disorder
  • gastroenteritis viral
  • lung disorder
2 - 5 years:
  • infusion related reaction
  • dyspnoea
  • chest discomfort
  • flushing
  • oropharyngeal pain
  • rash
  • drug specific antibody present
  • erythema
  • fatigue
  • heart rate increased
5 - 10 years:
  • adverse event
  • breast cancer
  • fatigue
  • hodgkin's disease
  • large intestine perforation
  • ligament rupture
  • rheumatoid arthritis
  • human papilloma virus test positive
  • smear cervix abnormal
10+ years:
  • asthma
  • fuchs' syndrome
  • hepatic enzyme increased
  • hysterectomy
  • intraocular pressure increased
  • pre-existing condition improved
  • rheumatoid arthritis
  • weight decreased
not specified:
  • infusion related reaction
  • dyspnoea
  • nausea
  • chest pain
  • arthralgia
  • headache
  • back pain
  • pruritus
  • flushing
  • rash

Most common drug interactions by gender *:

female:
  • infusion related reaction
  • dyspnoea
  • nausea
  • chest pain
  • headache
  • pruritus
  • arthralgia
  • rash
  • diarrhoea
  • flushing
male:
  • infusion related reaction
  • dyspnoea
  • chest pain
  • back pain
  • hyperhidrosis
  • pulmonary embolism
  • diffuse large b-cell lymphoma
  • febrile neutropenia
  • septic shock
  • arthralgia

Most common drug interactions by age *:

2-9:
  • infusion related reaction
  • red man syndrome
  • sickle cell anaemia with crisis
  • anaemia
  • road traffic accident
  • near drowning
  • paraesthesia
  • throat tightness
  • toothache
10-19:
  • infusion related reaction
  • colitis ulcerative
  • crohn's disease
  • dehydration
  • dyspnoea
  • hepatosplenic t-cell lymphoma
  • renal failure
  • sinus disorder
  • chest discomfort
  • collapse of lung
20-29:
  • infusion related reaction
  • dyspnoea
  • flushing
  • chest discomfort
  • back pain
  • headache
  • erythema
  • chest pain
  • chills
  • pain
30-39:
  • infusion related reaction
  • urticaria
  • rash
  • paraesthesia
  • back pain
  • dyspnoea
  • chest pain
  • pyrexia
  • blister
  • vision blurred
40-49:
  • infusion related reaction
  • dyspnoea
  • adenocarcinoma
  • nausea
  • arthralgia
  • tachycardia
  • flushing
  • vomiting
  • diarrhoea
  • drug ineffective
50-59:
  • infusion related reaction
  • pulmonary embolism
  • diffuse large b-cell lymphoma
  • febrile neutropenia
  • septic shock
  • dyspnoea
  • chest pain
  • cough
  • nausea
  • flushing
60+:
  • infusion related reaction
  • dyspnoea
  • chest pain
  • diarrhoea
  • back pain
  • pain
  • arthralgia
  • dizziness
  • hyperhidrosis
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Claritin and Remicade?

Can you answer these questions?

More questions for: Claritin, Remicade

You may be interested in these reviews

More reviews for: Claritin, Remicade

On eHealthMe, Claritin (loratadine) is often used to treat hypersensitivity. Remicade (infliximab) is often used to treat crohn's disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.